NCT00319085

Brief Summary

Background

  • Recently published studies confirm that preheating of femoral component enhances shear strength of implant-cement interface. Both Iesaka et al 2003 and Jafri et al 2004 showed reduction in cement porosity on cement-implant interface with preheated femur components. We will use the radiostereometry analysis (RSA) to investigate how the preheating of femur component influence on prosthesis survivorship. There are no clinical controlled studies performed to the date. The aim of the study
  • Comparison of the migration rates between preheated and non-preheated femur components, analyzed with RSA. Methods
  • Randomization of 80 patients into 2 groups with 40 in each. All patients will undergo standard hybrid total hip replacement. In group one the femur component (Bi-Metric, Interlock Biomet) will be preheated to 40 degrees of Celsius before cementation. In group two: the control group, the femur component will be of room temperature. We will measure the temperature at cement bone interface during the operation with use of thermocouple electrodes inserted through separate drill hole in the femur. The measurements will be recorded every 10 seconds. The patients will follow the standard postoperative rehabilitation program.
  • The RSA analysis will be performed the first day after the operation and at 3, 12, 24 months postoperatively.
  • The Dual-energy X-ray absorptiometry scanning (DEXA) of the femur will be performed at the first week after the operation and at 12 and 24 months postoperatively.
  • The patients will be followed both clinically and radiologically at 1 and 2 years after the operation (Harris Hip Score).
  • The results will be expressed as mean + SD (in mm). ANOVA statistical analysis will be used to confirm the differences between the groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started May 2006

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 27, 2006

Completed
Same day until next milestone

First Posted

Study publicly available on registry

April 27, 2006

Completed
4 days until next milestone

Study Start

First participant enrolled

May 1, 2006

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2010

Completed
Last Updated

April 10, 2015

Status Verified

April 1, 2015

Enrollment Period

3.9 years

First QC Date

April 27, 2006

Last Update Submit

April 9, 2015

Conditions

Keywords

Arthroplasty,Hip,Pre-heating,Radiostereometric analysis,Dual-Energy Radiographic Absorptiometry,

Outcome Measures

Primary Outcomes (1)

  • Stem migration in mm

    2 years

Secondary Outcomes (3)

  • Bone mineral density g/cm2

    2 years

  • Temperature at bone-cement interface, degrees in Celsius

    peroperatively

  • Serum- Titanium measurements in blood samples

    Not defined

Interventions

Total hybrid hip arthroplasty, cementation of femural component, preheating, radiostereometry, DEXA

Eligibility Criteria

Age70 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • The patients suffering of hip osteoarthritis

You may not qualify if:

  • The patients with ASA score \>II
  • The patients with cancer
  • The secondary coxarthrosis after the trauma
  • Any vascular or neuromuscular diseases affecting the hip.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Farsoe Hospital, Northern Orthopaedic Division

Farsø, 9640, Denmark

Location

MeSH Terms

Conditions

Osteoarthritis, Hip

Interventions

Arthroplasty, Replacement, Hip

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Officials

  • Mogens B Jørgensen, M.D.

    Northern Orthopaedic Division, Aalborg University Hospital, Denmark

    PRINCIPAL INVESTIGATOR
  • Mogens B Laursen, M.D., Ph.D

    Northern Orthopaedic Division, Aalborg University Hospital, Denmark

    PRINCIPAL INVESTIGATOR
  • Lotte Borgwardt, dr.

    Frederikberg Hospital, Copenhagen

    PRINCIPAL INVESTIGATOR
  • Kjeld Søballe, Ph.D., MD.

    University Hospital of Aarhus

    STUDY CHAIR
  • Poul T Nielsen, M.D.

    Northern Orthopaedic Division, Aalborg University Hospital, Denmark

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2006

First Posted

April 27, 2006

Study Start

May 1, 2006

Primary Completion

April 1, 2010

Study Completion

April 1, 2010

Last Updated

April 10, 2015

Record last verified: 2015-04

Locations